• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

NVV:GR

3.364 EUR 0.023 0.68%

As of 02:16:16 ET on 07/11/2014.

Snapshot for Novavax Inc (NVV)

Open: 3.284 Day's Range: 3.284 - 3.364 Volume: 0
Previous Close: 3.387 52wk Range: 1.721 - 5.197 1-Yr Rtn: +74.39%

Stock Chart for NVV

No chart data available.
  • NVV:GR 3.364
  • 1D
  • 1M
  • 1Y
3.387
Interactive NVV Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NVV

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.2620
Est. PEG Ratio -
Market Cap (M EUR) 800.82
Shares Outstanding (M) 238.06
30 Day Average Volume 464
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/08/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NVV

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for NVV

Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.

Stanley C ErckPresident/CEOBarclay A Phillips "Buck"Senior VP/CFO/Treasurer
Russell P Wilson "Rip"Senior VP:Business DevelopmentJohn J TrizzinoSenior VP:Commercial Operations
More Company Profile & Key Executives for NVV

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil